Larvol Delta - A-Phase-1-Study-to-Assess-BDTX1535-an-Oral-EGFR-Inhibitor-in-Patients-with-Glioblastoma-or-NonSmall-Cell-Lung-Cancer

BDTX-1535 - Black Diamond Therap

https://www.aacr.org/wp-content/uploads/2023/09/MTCT2023_postersC_titles.pdf

Helena Yu

Sep 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next